Related by context. All words. (Click for frequent words.) 67 1a 65 4a 64 6a 63 3a 63 5a 62 #a [003] 62 7a 54 1e 53 Reproduced Record RR 52 9a 52 NJSA #A 51 NJSA 2C :2 51 1d 50 END FOOTNOTE FOOTNOTE 49 #.#-# b [002] 49 :7 48 § #E 48 § #.# [004] 48 #.#-# [020] 48 Income Tax Regs 48 #a# [002] 48 8a 48 :3 48 0a 47 Eq. 47 #.#-# [005] 47 Supplemental Figure 47 #.#-# [021] 47 :5 47 See OCGA § 47 #.#-# b [001] 47 § #.#-# [004] 46 § § #-#-# [001] 46 -2 -3 46 #a #a [002] 46 :4 46 § #-#-# b [003] 46 NJSA 2C :5 46 2r 46 ITEPA 46 #.# 5T 45 See TCA § 45 #,#,# [020] 45 document.write unescape % 45 C.# 45 Ala. Code § 45 BeS 45 #a #a [001] 45 2HR 45 Supplementary Table 45 #r [003] 45 Repl. 45 7r 45 NJSA #:#-# [004] 45 -1 45 supra § 45 #.#A [005] 45 #-#-#.# [004] 45 See Restatement Second 45 ,8 45 Judgments § 45 0D 45 45 USC § #a [001] 45 CFR #.# [008] 45 1g #a 45 L0 44 #A NCAC 44 d 44 NJAC 6A 44 7R 44 #-#.# [014] 44 1ac 44 Fig. 2C 44 USC § #a [002] 44 1A 1B 44 #-#.# [009] 44 OCGA § 44 4RBI 44 #,#,#,# [006] 44 #-#-#.# [005] 44 #.# subd [004] 44 #p. 44 #-#-# [068] 44 Peginterferon Alfa 2a 44 8b 44 ,4 44 § § #.# [002] 44 2A 2B 44 G# [003] 44 4A 4B 44 4e 44 NJSA #:# [001] 44 CFR § #.# [006] 44 § #-#.# [001] 44 ω 44 1G 1A 43 #A [006] 43 #AB [001] 43 #S #S [003] 43 See USSG 43 7b 43 1.a. 43 CODE § 43 h 43 #-#-# [067] 43 #-#.# [017] 43 Contracts § 43 1as 43 CFR #.#b 43 #.# #.# [008] 43 9D 43 8D 43 memset 43 RC #.# B [001] 43 pairwise comparisons 43 NJAC #:#-#.# 43 NJSA #:# [002] 43 CFR #.# [001] 43 #-#-# [059] 43 #d# [001] 43 manmohan@sansad.nic.in soniagandhi@sansad.nic.in oAprimo Marketing TM 43 USC #d 43 p 43 2AB 43 USC § #f 43 CFR § #.# [004] 43 GLc 43 #A [001] 43 8e 43 E#M# 43 NJSA 2A #A 43 IIIB 43 sv 43 2E 43 len = 43 :9 43 #.#A [004] 43 code FI# Minimum 43 g cm 43 #,#,# [024] 43 Fig. 1b 43 6e 43 1A 43 Equity GROWTH ISIN 43 #F #F [002] 43 2a 2b 43 a7 43 cmt 43 USC § #c 43 Ind. Code § 43 = sizeof 42 9b 42 CFR § #.# [008] 42 :2 42 CFR § #.# [002] 42 Supplementary Appendix 42 § #.# [002] 42 § #.#.# [002] 42 a2 42 #-# [005] 42 Gv 42 ligand receptor 42 IC § 42 Hall BF Poster 42 CFR § #.# [001] 42 Torts § 42 1F 42 PURSUANT TO SECTION 42 #b #b 42 #,#,#,# [004] 42 4b 42 #-#-# [074] 42 SDCL 42 9e 42 ≈ 42 2b 42 #b #S 42 #W #L 42 5E 42 6P 42 Subsections 42 Vernon Supp 42 Kenilworth Wardens Jnrs 42 CFR § #.#b 42 #AA [002] 42 S1 S# [001] 42 Section #-#-# [006] 42 NJSA #:# C 42 See id 42 § #.#-# [007] 42 #A.# [003] 42 TCA § #-#-# [003] 42 HRS § #-# [002] 42 Id. § 42 Ref. 42 6D 42 Article XVIII 42 sqrt 42 Opp'n 42 Fig. 1E 42 #e [003] 42 sec. 42 Fig. 3B 42 Fig. 2B 42 2C :# 42 Supp. 42 wedge Hole TC# 41 EndoTAG ® 41 § #A [001] 41 Fig. 4c 41 = .# 41 function var = 41 RH DONNELLEY CORPORATION 41 :6 41 8A 41 #a# [001] 41 Cherry Hinton Lions 41 yl 41 N0 41 κ 41 χ 41 Cal. Rules 41 ¼ l 41 1r 41 5F 41 dV 41 8g 41 Date Amount 41 1I 41 Figs. 41 IIIb 41 GONZALES grounded 41 Fv 41 Va. Code § 41 JEDEC Level 41 USC § #u 41 xxxv 41 Y# [004] 41 fig. S2 41 CLY 41 Colo. Sess 41 WHITELEY grounded 41 IIb 41 + sizeof 41 #-#.# [016] 41 #.# subd [003] 41 4w 41 #.#.# [023] 41 6r 41 Timed Finals 1 41 NCGS § 41 § #-#-# [004] 41 #F [005] 41 NJSA #:#-# [003] 41 NYCRR 41 § #a [002] 41 0G 41 neutropaenia 41 1b 2b 41 t6 41 +2 41 Rule #b# 41 rbds 41 NIELSEN grounded 41 alt Sec 41 q = 41 7P 41 Seq 41 Fig. 1c 41 #g# 2 41 bunt SAC 41 t1 41 fig. S3 41 See USSG § #B#.# 41 #d [002] 41 Gly 41 OGJ Mar. 41 Marston RBL 41 Exh 41 +2 +2 41 unsigned char 41 4d 41 3r 41 2B 41 #a [001] 41 Marle Place Wanderers 41 6pts 41 S0 41 univariate 41 Figure 3a 41 ρ 41 sid = 41 s2 41 Botley Utd 41 λ 41 #-#-# [019] 40 Article XVII 40 CFR § § 40 NEGRON K. grounded 40 § § #-# [003] 40 BEL Kawasaki 40 Initiated Phase 40 #ff [002] 40 Wyvern Res 40 mRS 40 Woodloes Jnrs 40 #A #B [002] 40 c 40 2B 3B 40 q 40 CFR § #.# [003] 40 dT 40 CFR § #.# [007] 40 WALTON grounded 40 8d 40 weighted avg 40 #A #A [002] 40 7d 40 7e 40 USC § #a [003] 40 glutamyl 40 9R 40 Woitas grounded 40 #,#,#,#,#,# [002] 40 Cricklade Tn 40 σ 40 RAMIREZ grounded 40 RCW #.#A.# 40 USC § #b [002] 40 Fig. 3b 40 Somerville Hse 40 interferon α 40 #-#-# [040] 40 dbl 40 5d 40 Internal Revenue Code § 40 b 40 § #-#-# [005] 40 Fig. 2a 40 #a #b [002] 40 Subparagraph 40 0A 40 4E 40 rho 40 Defs. 40 4F 40 IIIA 40 1D 40 θ 40 modulo 40 dI dV 40 beta tubulin 40 CFR #.# [002] 40 suppl 40 Kewstoke Lions 40 serine 40 Cropredy Res 40 Ibid 40 ν 40 1LB 40 #E# [003] 40 NJSA 40 8E 40 2b rbi 40 #-#-#-# [018] 40 Fig. 1a 40 5A 5B 40 FOURTH DOWN EFFICIENCY 40 Prs D 40 RC #.# F 40 Mantel Haenszel 40 Fig. 3d 40 HOCH grounded 40 #.#,#.# [001] 40 Cheltenham Saras 40 Complaint ¶ 40 Placings 40 QRS duration 40 #-#,# [003] 40 #bis 40 Wanilla Rangers 40 #,#,#,# [003] 40 Launton Spts 40 See USSG § #D#.# 40 5alpha reductase 40 â ‰ ¥ 40 Plat Book 40 near Warrenton GPIN 40 # endif 40 6G #A 40 #.#D [002] 40 ‰ ¥ 40 microg 40 Pro Rata 40 B.2 40 6b 40 FIRST PERIOD Scoring 40 0E 40 section# 40 8w 40 A1 A2 40 Neurol 40 #-#-# [011] 40 vi vii 40 t7 40 drlg 40 Chicoutimi QMJHL 40 streak 1g 5a 40 Δ 39 t4 39 #.# subd [006] 39 Section #.#.# [001] 39 Kooper Bond 39 #.# 5f #yd [002] 39 #.#A [001] 39 #.# subds [001] 39 THE COSMOS ROCKS 39 Income Tax Assessment 39 VIII 39 Pa.CSA § 39 Highbridge Res 39 Vb 39 La Ce Pr 39 #f [003] 39 #.# Kenyan Shilling 39 pmol 39 2t 39 § #.# [001] 39 Polegate Grasshoppers 39 6L 39 NYSE Arca Equities 39 Tples WoW 39 #mA #mA 39 Bilton Ajax 39 ^ sup #m 39 ECOG PS 39 SEE PAGE 39 Fig. 2c 39 #-#-#.# [002] 39 hwt 39 DC Code § 39 9w 39 #A #A [001] 39 A2 A3 39 #P# [004] 39 rev. 39 r2 = 39 hcp #-# [001] 39 #a [004] 39 w. 39 Adur Ath 39 9d 39 La.RS #:# [003] 39 B.1 39 = strlen 39 #,#,# [010] 39 Docket Entry No. 39 0 39 Def. s 39 TABLE OF CONTENTS 39 #ff [001] 39 T1 T2 39 μV 39 CLUFF grounded 39 Futures Ordinance 39 Kingham AB 39 #,#,#,#,# [002] 39 Cf 39 violated SCR #:#.# 39 Dirk Cowburn Coudersport 39 regression coefficients 39 Prs G 39 CFR § § #.# [002] 39 TVID 39 Civil Procedure § 39 Ord. 39 Propagation Forecast Bulletin 39 Coleshill Utd 39 Berinsfield CC 39 B2 B3 39 Loss Severity 39 P. #a 39 hcp 39 #/#.# [008] 39 HOLLINGER E grounded 39 #b [004] 39 CFR #.# [005] 39 #C# [006] 39 ß 39 Nucl Med 39 l l 39 unsigned int 39 #CCC 39 Section #.# [001] 39 B# [004] 39 Br J Dermatol 39 HVW 39 4N 39 Donnington CC 39 deoxy 39 sizeof 39 OCGA 39 Hanney Utd 39 #N #N 39 S7 S# 39 FIRST PERIOD 39 3Z 39 ,3 39 Highcroft Racing Acura ARX 39 #-#-#.# [001] 39 Cra 39 #b# [004] 39 Apolipoprotein 39 #.#f [001] 39 Roughing Minor 2 39 -Dan Futterman 39 Lw 39 39 i #.# subds 39 #-#-#-# [041] 39 U# Div 39 #-#.#.# [001] 39 DLTs 39 0w 39 G# [006] 39 La. RS #:# [002] 39 ,5 39 auc 39 RC #.# B [002] 39 HIGH STICKING 39 Banbury Utd Yth 39 g t Ounces 39 2S 39 Easington Spts 39 abstr 39 Poss Cs Pg 39 microRNAs miR 39 RES# [002] 39 -Wavelink Corporation www.wavelink.com 39 LSA RS 39 Studley Sporting 39 = NULL [002] 39 b Vernon Supp 39 Abstract Number 39 Fig. 39 CrR #.# 39 NAKAYAMA grounded 39 rnd 39 § #.# [006] 39 Qty 39 PS § § 39 Gradoville grounded 39 39 SHOT PUT 39 #AB [002] 39 0xff 39 z z 39 pT 39 - -Denis Restoule 39 #A.# [005] 39 Littlemore RBL 39 = #.#-#.# 39 § 8C 39 Counter Strike CEVO Pro 39 IC § #-# 39 Nephrol 39 PEG IFN 39 Morizio grounded 39 NJSA #A #A 39 ABN AMRO BANK 39 Fig. 1A 39 g 39 interleukin IL 39 T0 39 Denotes 39 struct 39 Andrea Frizell . 39 Aliquam 39 HOOKING 39 cx 39 Interleukin IL 39 RSA #:# [001] 39 d SPLC 39 #.#A [006] 39 § #.# b 39 NJSA #:#-# [001] 39 ,2 38 OCGA § § 38 Legal #.# 38 Emerg Care 38 FONT size 38 Docket # 38 Clevedon Dons 38 rh 38 transferase 38 forf 38 IRC § 38 Abingdon Tn 38 Randomized phase 38 Grendon Rgrs 38 HT 1A 38 Ferlay J et al 38 Np 38 subthreshold 38 Pl. 38 Vc 38 Gov't Code § 38 ref. 38 Farrer Place 38 #.#E [004] 38 NDCC § 38 #-#-#-# [002] 38 FOF ¶ 38 methoxy 38 BRAMBLE BAY Open 38 4HR 38 1First Period 1 38 Didcot Cas 38 #as [001] 38 DARRA CEMENTCO 38 Def. 38 #a subdivision 38 7E 38 T3 T4 38 Draycott Res 38 Cirencester Utd 38 b Disclosure SmallcapInsights.com 38 1h 38 section #-#-# [002] 38 Bulk Ex Kandla 38 SECOND PERIOD 38 subscores 38 § #-#-#.# 38 9L 38 methyltransferase 38 9P 38 TCA § 38 #-#-#-# [036] 38 = null 38 3d ed 38 7F 38 art. 38 +3 38 Bicester Tn 38 2R 38 Ram Heid 38 Sgles J 38 Pl. s 38 MCL #.# [002] 38 . - [021] 38 W6M 38 streak 3g 4a 38 USC § #A 38 streak 2g 3a 38 C1 C3 38 WALTON flied 38 mol L 38 Cv 38 #I [003] 38 PO# [002] 38 η 38 Challow Utd 38 Washingtonville Wash 38 NO spud #-#-# 38 #T# [005] 38 #-#,# [007] 38 § #-#.# [003] 38 subsection f 38 dH 38 Subsection c 38 -# [003] 38 App'x 38 #-#-# [013] 38 § § #.# [001] 38 #-# #-# [013] 38 #B# [007] 38 4y 38 ESMO Accepted Abstract 38 Resp't 38 nausea dehydration dyspnea 38 9g 38 KELLER P. grounded 38 ibid 38 n.5 38 IRCP 38 Pilittere grounded 38 #PD 38 See ARS § 38 2 38 pE 38 Dbl 38 #D [003] 38 ICVC 38 USCS § 38 Subd 38 #.#-# [006] 38 #G# [002] 38 W4 38 8h 38 ,1 38 B4 38 #-#.# [026] 38 Fund GROWTH ISIN 38 Direct xi Indirect 38 Compl 38 J Am Soc 38 Tp 38 Tutties 38 x 38 Goms Mill 38 mmj 38 2R 2RBI 38 5 hydroxytryptamine 38 VILLEZCAS grounded 38 2G 2A 38 #S #S [001] 38 1D 1E 38 doc. # 38 #/#/# [032] 38 Banbury Tn Yth 38 Dick Wardman 38 Kara Bonenberger Northampton 38 HOUSE Remains 38 § § #-#-# [002] 38 Section #-#-# [005] 38 #N Range [001] 38 § #-# [004] 38 gp 38 td tr 38 Fig. 1C 38 #.#m ECAC 38 6w 38 #AA [001] 38 c.# [001] 38 #.# subdivision [003] 38 Excludes amortization 38 Sentencing Guidelines Manual 38 -Genereaux 38 Eur Urol 38 6h 38 THIRD PERIOD Scoring 38 # DOI 38 Restatement Second 38 5pts 38 C'ship Prs 38 #beta hydroxysteroid dehydrogenase 38 #-#/#L #-#/#L 38 figs. 38 § #:# [001] 38 LS5 38 #.#f [002] 38 [013] 38 2ac 38 3ac 38 #j [001] 38 § #-#-# b [001] 38 -Joel bro Benji 38 Clin Endocrinol 38 #-#-# [081] 38 Art. 38 2 [002] 38 3w 38 Oxford Blackbirds 38 dI 38 document.write sline 38 +5 38 uM 38 #A# #A# 38 ALT elevation 38 OL# 38 Direct Indirect 38 Colorado Revised Statutes 38 HRS § #-# [001] 38 MEY 38 Almondsbury Tn 38 2nd Rnd 38 WB #-#/# #-#/# 38 Chippy Swifts 38 DR #.#.# 38 # PBTD # 38 Pv 38 Pp 38 Sht 38 ε 38 argc 38 5First Period 1 38 Chipping Norton Tn Swifts 38 B#.# [002] 38 Cn 38 paronychial inflammation 38 ErP 38 Lg nk 38 Leamington Jnrs 38 Timed Finals 38 7w 38 recodified 38 9T 38 USC § #d 38 2First Period 1 38 #-#/#L #/#L 38 1A Risk Factors 38 μg d 38 VII 38 8-( 38 antitrypsin 38 Eur J Cancer 38 #S #S [002] 38 #a #b [001] 38 #/#/# Appendix 38 PURSUANT TO RULE 38 DTR #.#.# b 38 BP# [003] 38 J Clin Oncol 38 conventional DMARDs 38 jrw 38 ,#,# [002] 37 SPECIFICS Cotton Valley 37 Prob 37 topo 37 4px 37 #Ga 37 ODNs 37 -2 -4 37 § #.# [003] 37 Tonbridge Jnr 37 Professional Conduct Rule 37 T#N R#E 37 n8 37 CFR #.# [007] 37 yr -1 37 HEIGHT = 37 #.#-# [003] 37 ps :# 37 vl 37 mg qd 37 Lnk 37 AUC0 37 Bampton Tn 37 THIRD PERIOD 37 1S 37 Barford Utd 37 Avg. 37 #,# bis 37 B8 37 0 document.write sline 37 USSG § #B#.# [002] 37 #.#-# [029] 37 § #-#-# c [001] 37 discriminant analysis 37 Chandos Arms 37 NASD Marketplace Rule 37 Old Woodstock Tn 37 R1 R2 37 cm ² 37 Hove Rivervale 37 df 37 str = 37 CFR § #.# [005] 37 Å -1 37 BRAMBLE BAY 37 3px 37 Harshbarger Subd 37 2g 5a 37 aza 37 phosphodiesterase PDE 37 HCV genotype 1a 37 Contact Thea Lavin 37 Follicular Lymphoma 37 d Clayfield 37 nH 37 Gln 37 ALGESTER 37 fA 37 CFR #.# c 37 APN #-#-# [002] 37 Exs 37 Cts 37 #a #a [003] 37 assigned Rating Outlooks 37 compl #-#-# tested [002] 37 subds 37 BORDER = 37 Uffington Utd 37 #/#-#/# [005] 37 Miscellaneous Receipts 37 strlen 37 Chk 37 High Density Residential 37 USC § #k 37 alpha2 37 ^ F FDG 37 dinucleotide 37 #px [002] 37 KOOS 37 p# [004] 37 #BB #K 37 regulat 37 Suppl 37 Vrms 37 #B [002] 37 #/#L #-#/#L 37 Code § #-# [002] 37 quoting Restatement Second 37 WAIS III 37 F FLT 37 #-# #-# [011] 37 eg. Proved Producing 37 #/#/# Appendix 3B [003] 37 + - [002] 37 § #b [001] 37 Noncritical violations found 37 Sh hd 37 pN 37 § § #v 37 fructosamine 37 ONE METER DIVING 37 Gla 37 +7 37 + 37 #/#/# [019] 37 2B 2RBI 37 Section1 37 HRS § 37 @ #V AC 37 Golcar Lib B 37 #.#pt [001] 37 vphl Norwegian Securities 37 #D Filings 37 scs 37 BORDER = 0 37 § #.#.# [001] 37 :1 37 Slashing Minor 37 CFR § § #.# [001] 37 s6 37 Doc. 37 Figure 1C 37 #,#,#,# [011] 37 BCS Bardwell Res 37 5G 5A 37 NJSA #:#-# [002] 37 INA § 37 Inductance 37 KSA #-# [001] 37 1R 37 LME STOCKS 37 -#.# ± [002] 37 #s #w 37 CORE OM 37 § #-#-# [007] 37 spud #-#-# drlg [002] 37 NJSA 2C :# 37 1st Rnd 37 D1 D2 37 -India Kanishka bombing 37 LSU . 37 ^ ^ sup 37 E.# [001] 37 nonparametric 37 #,#,# [016] 37 compl #-#-# tested [004] 37 § #c 37 - Adjusted [017] 37 KEA Res 37 Pearson correlation coefficient 37 T2N 37 A1 A2 A3 37 nm excitation 37 t3 37 Trk 37 FAR #.# 37 -# -# [006] 37 Nr 37 #.# [023] 37 USC § #o 37 T2 T3 37 SECOND PERIOD Scoring 37 7J 37 FUQ 37 Interval Au 37 #a# [003] 37 jl 37 = argv 37 7t 37 bromo 37 #-#-# [004] 37 7g #a 37 U/G- deg deg 37 #R [003] 37 #:#-#:# [001] 37 ORDINARY SHARES OF 37 4g 4a 37 NJSA #A :# 37 1t 37 hd #-#/#L 37 suppl. 37 x3 37 Section #-#-# [004]